Why should patients with type 2 diabetes be screened for liver disease?
Leading consultant gastroenterologist Dr Jude A. Oben provides a detailed insight into screening patients with type 2 diabetes for MASLD, via evidence reflecting the importance of this process being added to future UK clinical guidance.


















